Skip to content
value.today

Itron, Inc.: valuation

What the market value assumes, and what the company's own statements and its peers' prices would put it at. Every assumption is yours to change.

Cash-flow value and what the price assumes

$M

Average of FY2023–FY2025 (cash from operations less capital spending), from the statements below.

%

Starts at revenue growth over the last three years, 9.7% a year (statements).

%

US Treasury 10-year yield on Nov 13, 2026: 5.15% (US Treasury).

%

Your assumption: the extra yearly return you want for holding shares rather than Treasuries. 5% is a round starting figure, not data.

%

Your assumption: long-run growth, usually near inflation. It must stay below the discount rate.

$M

Debt less cash at the end of FY2025 (statements); negative means more cash than debt.

What today's price assumes

A market value of $4.2 B means free cash flow growing 7.4% a year for 10 years, then 2.5% for ever, at a 10.15% discount rate.

Revenue grew 9.7% a year over the last three years.

Cash-flow value of the shares
$4.9 B
+19% against the market value
Value of the whole business
$5.2 B
before net debt
Value from after year 10
57%
of the business value

Against the market value, for other rates

Cash-flow value of the shares as a percentage above or below today's market value; your inputs in the middle.

Sensitivity of the cash-flow value to the discount rate and the growth rate
Discount rate ↓ / growth →4.65%7.15%9.65%12.15%14.65%
8.15%+13%+38%+69%+106%+151%
9.15%-6%+15%+40%+70%+107%
10.15%-19%-2%+19%+44%+74%
11.15%-30%-15%+3%+24%+49%
12.15%-38%-25%-10%+8%+30%

On one scale

Bars: from the 25th to the 75th percentile multiple of the peers, the line at the median; dot: the cash-flow value with your inputs.

P/EP/E of Scientific Technical Instruments: $8.2 B to $14.1 B, median $10.5 BPrice to salesPrice to sales of Scientific Technical Instruments: $6.8 B to $16.5 B, median $10.6 BPrice to bookPrice to book of Scientific Technical Instruments: $4.6 B to $10.5 B, median $6.5 BCash-flow value$0 M$4.4 B$8.9 B$13.3 B$17.8 BMarket value $4.2 B

Your own DCF model

A full discounted-cash-flow model of Itron, Inc., started from its filings: revenue growth and margins year by year, bear, base and bull cases, the WACC and its parts, sensitivity tables and a value per share against the dated market price. Save it, share it with your team or by a read-only link.

Open the DCF model

Against the industry Scientific Technical Instruments

Multiples of its companies with a market value at most 60 days old, times Itron, Inc.'s own figures of FY2025.

Values from the peers' multiples
MultiplePeers (25th / median / 75th)Itron, Inc.Applied toValue (25th to 75th)Companies
P/E27.3× / 34.8× / 46.9×14.8×net income $301 M$8.2 B to $14.1 B11
Price to sales2.9× / 4.5× / 7.0×1.8×revenue $2.4 B$6.8 B to $16.5 B13
Price to book2.7× / 3.8× / 6.1×2.4×book equity $1.7 B$4.6 B to $10.5 B13

Peers' multiples from the distributions by industry; the company's figures from its statements below. A multiple says what similar companies cost, not what this one is worth.

Against its own history

Itron, Inc.'s multiples at each month end with a market cap on file, Jan 2020 to Oct 2026, each against its own median.

P/E

15.2×

Now below its median of 17.7×, in the bottom quarter of its range; range 12.8× to 79.0× over 25 months.

0×20×40×59×79×202120222023202420252026P/E 15×Median 18×

Price to sales

1.8×

Now close to its median of 1.9×; range 1.1× to 2.6× over 30 months.

0×1×1×2×3×2020202120222023202420252026Price to sales 2×Median 2×

Price to book

2.4×

Now below its median of 3.2×, in the bottom quarter of its range; range 2.0× to 5.0× over 30 months.

0×1×2×4×5×2020202120222023202420252026Price to book 2×Median 3×

as of Oct 30, 2026. Market caps: the dated values on file since 2020, and in between the SEC's fails-to-deliver closing price times the share count on the latest 10-K or 10-Q cover. Each month divides by the last twelve months' results that had been published by then (a quarter 45 days after it ended, a fiscal year 60 days after), so the past is not read with figures that came out later; months with a loss give no P/E. Newest month: Oct 30, 2026.

The statements it starts from

USD millions at each year's exchange rate; free cash flow = cash from operations less capital spending.

Figures from the annual statements
Fiscal yearRevenueNet incomeCash from operationsCapital spendingFree cash flowNet debtSource
FY2025to Dec 31, 2025$2.4 B$301 M$406 M$23 M$383 M$245 MSEC annual report (10-K, 20-F)
FY2024to Dec 31, 2024$2.4 B$239 M$238 M$31 M$208 M$214 MSEC annual report (10-K, 20-F)
FY2023to Dec 31, 2023$2.2 B$97 M$125 M$27 M$98 M$158 MSEC annual report (10-K, 20-F)
FY2022to Dec 31, 2022$1.8 B$-10 M$25 M$20 M$5 M$258 MSEC annual report (10-K, 20-F)
FY2021to Dec 31, 2021$2.0 B$-81 M$155 M$35 M$120 M$297 MSEC annual report (10-K, 20-F)
FY2020to Dec 31, 2020$2.2 B$-58 M$110 M$46 M$63 M$729 MSEC annual report (10-K, 20-F)

Each figure as filed; the full statements with every line and its filing are on the company page. Market value $4.2 B on Oct 30, 2026.

How it is worked out: the cash-flow value is free cash flow grown at the first-stage rate for the years chosen, then at the long-run rate for ever, each year discounted at the risk-free rate plus the equity risk premium, less net debt. What the price assumes is the first-stage growth that makes that value equal today's market value. The starting cash flow, growth and net debt come from the statements; the risk-free rate from the US Treasury; the premium and the long-run growth are assumptions and are labelled so. This is arithmetic on reported figures, not advice.